Dihydroethidium CAS 104821-25-2

Starting materials: Choose a suitable starting material, which may be a compound containing a benzene ring and an amino group.

Solvents and catalysts: Select appropriate solvents (such as ethanol, methanol, etc.) and catalysts (such as transition metal catalysts) based on the type of reaction.

Reaction type: Substitution reaction or coupling reaction of aromatic hydrocarbons.

Specific steps: Under the action of a catalyst, the starting material is reacted with appropriate benzene ring introducing reagents (such as phenylboronic acid, halogenated benzene, etc.) to introduce a benzene ring structure.

Chemical equation: Due to the unknown structure of specific reactants and products, the general formula is used here to represent:

Starting material+benzene ring introduction reagent → Intermediate product 1

Reaction type: Amination reaction or amine substitution reaction.

Specific steps: Under appropriate conditions, react intermediate product 1 with amination reagents (such as amines, azides, etc.) to introduce or modify amino groups.

Chemical equation:

Intermediate product 1+amination reagent → Intermediate product 2

Reaction type: hydrogenation reaction.

Specific steps: Under the action of catalysts (such as platinum, palladium, etc.) and hydrogen gas, the intermediate product 2 is hydrogenated to obtain DHE ingot or its analogues.

Chemical equation:

Intermediate product 2+H2 → DHE ingot (or similar)

Purification: Purify the product through methods such as recrystallization and column chromatography.

Characterization: Use techniques such as mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance to characterize the product and confirm its structure and purity.

DHE is not a naturally occurring substance but a synthetic compound chemically derived from ethidium bromide. Its developmental timeline can be divided into three phases: initial synthetic creation, preliminary biological application, and revision of its mechanism of action.Early research centered on ethidium bromide, a DNA intercalating dye.

To investigate the reversible binding between ethidium and nucleic acids, researchers performed two-electron reduction of ethidium bromide using sodium borohydride, which yielded neutral DHE lacking strong DNA-binding affinity for the first time.

This synthetic route laid the foundational framework for DHE, which was initially only subjected to basic spectroscopic characterization as a reduced intermediate of ethidium.In 1989, Olive pioneered the use of DHE (then referred to as hydroethidine) for measuring cellular oxidative status.

It was observed that DHE can cross cell membranes and produce red fluorescence localized to cell nuclei upon oxidation. Olive's group first attempted to label hypoxic tumour cells based on this differential oxidation property, launching research into DHE as a biological probe.

Multiple studies published throughout the 1990s further put forward a hypothesis: intracellular superoxide anion oxidizes DHE into ethidium cation, and superoxide levels can be reflected via the intercalation-derived fluorescence of ethidium with DNA. This hypothesis rapidly established DHE as a mainstream fluorescent probe for oxidative stress detection.

In 2003, the Kalyanaraman team published a landmark corrective study that overturned the previous understanding of the reaction. The team verified that the specific reaction product of DHE with superoxide anion is not ethidium, but 2-hydroxyethidium.

Ethidium generated via generic oxidative stress pathways merely indicates non-specific oxidation, resolving a long-standing misperception surrounding the assay.

Subsequent investigators developed MitoSOX, a mitochondria-targeted derivative, based on this clarified chemical mechanism. Meanwhile, high-performance liquid chromatography (HPLC)-based quantitative protocols were established to distinguish the two distinct fluorescent products, refining the standardized workflow for DHE application in oxidative biology research.